Cognition and Memory Enhancement Drugs: Technologies and Global Markets

  • ID: 4587231
  • Report
  • Region: Global
  • 155 Pages
  • BCC Research
15 % OFF
until Oct 31st 2018
1 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Cambridge Cognition
  • Cogstate Ltd.
  • Nootriment
  • Onnit Labs Llc
  • Pfizer Inc.
  • MORE

Report Scope:

This research report presents an in-depth analysis of the global cognition and memory-enhancing drugs market by application, product categories, and regional markets. The report includes key cognition drugs that are incorporated in several therapeutic treatment methods. It discusses the role of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global cognition and memory-enhancing drugs market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and regions such as the U.S., Europe, and China.

The cognition and memory-enhancing drugs market is segmented mainly into eight components: Aricept, Exelon, Reminyl, Namenda, Adderall, Ritalin, Dexedrin, and other cognition drugs. This market is further segmented on the basis of applications, which helps in understanding the potency of these memory enhancers in several therapeutic treatments. The market study is detailed for products based on applications as well as its further implication on the research and development area. These two segmentations are also discussed in detail for the given period. The market is segmented by region into the North America, Europe, Asia-Pacific, and ROW. Companies profiled in this report include Pfizer, Novartis, Shire Pharmaceuticals, Allergan plc, Barr Pharmaceuticals, and Cephalon.

Report Includes:

  • 34 data tables and 14 additional tables
  • An overview of the global market for cognition and memory enhancement drugs
  • Analyses of global market trends, with data from 2016 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • An overview of the ethics and side effects of cognition and memory enhancement drugs
  • Market analyses by application, product, and region
  • Assessment of patent litigation claims
  • Insight into the competitive landscape, including mergers and acquisitions and new product launches
  • Profiles of key companies in the market, including Pfizer, Novartis, Shire Pharmaceuticals, Allergan Plc, Barr Pharmaceuticals, and Cephalon

Membership Price:

Contact us for membership pricing.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Cambridge Cognition
  • Cogstate Ltd.
  • Nootriment
  • Onnit Labs Llc
  • Pfizer Inc.
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Market Definition
  • Ethics and Cognition and Memory-enhancing Drugs
  • Treatments Available for Dementia
  • Cholinesterase Inhibitors
  • Memantine
  • Nondrug Treatments for Dementia
  • Availability of Dementia Treatments
  • Treatment for Other Symptoms of Dementia Including Aggression and Anxiety
  • Side Effects of Cognition and Memory-enhancing Drugs
  • Benefits and Side Effects of Consuming Cognition Drugs
  • Guidance Given by the American Academy of Neurology
  • Current Cognition Enhancers
  • Physical Exercise
  • Diet and Nutrition
  • Social Engagement
  • Sleep
  • Computer Training Programs
  • ADHD Drugs, Symptoms, and Side Effects
  • Use of Pharmacological Cognitive Enhancers by Healthy Individuals
  • Enhancement of Executive Functions
  • Use of Cannabis in Adolescence
  • Use of Illicit and Prescription Drugs for Cognitive or Mood Enhancement Among Surgeons
  • Study Reported in BMC Medicine in 2013 and Other Studies
  • Executive Functions
  • Working Memory
  • Neuropsychiatric Disorders
  • Enhancer Drug Use Trends Among Youth
  • Future Prediction of Social Acceptance of Cognition and Memory-enhancing Drugs
  • Patent Litigation Claims in the Cognition and Memory-enhancing Drugs Market
  • Different Patent Infringement Types
  • Clinical Guidelines
  • Clinical Guidelines for Cognitive and Behavioral Problems in Dementia
  • Clinical Practice Guidelines for Dementia in Australia
  • Technology Trends
  • Recent Studies Highlighting Potential of Cognition Drugs in Chess
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities

Chapter 4 Global Cognition and Memory-enhancing Drugs Market Breakdown by Product Type

  • ADHD, Attention Deficit Hyperactivity Disorder; MPH, Methylphenidate
  • Prohibition of Cognition Enhancers in Healthy Individuals
  • Global Cognition and Memory-enhancing Drugs Market
  • Aricept
  • Exelon
  • Reminyl
  • Namenda
  • Adderall
  • Ritalin
  • Dexedrin
  • Other Cognition and Memory-Enhancing Products

Chapter 5 Global Cognition and Memory-enhancing Drugs Market Breakdown by Application

  • Alzheimer's Disease
  • Brain Changes Associated with Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) - A Potential Precursor to Alzheimer’s and Other Dementias
  • Recent Case Study on Alzheimer's Disease Drug: 2017
  • Case Study on Alzheimer's Disease Drug: 2015
  • Mortality and Morbidity Because of Alzheimer's Disease
  • Healthcare Expenditure on Alzheimer's Disease
  • Emergence of Biomarkers as Diagnostic Tool for Alzheimer's Disease
  • Alzheimer's Disease Facts
  • Difference between Alzheimer's Disease and Dementia
  • Susceptibility Factors for Alzheimer's Disease
  • Causes of Alzheimer's Disease
  • Diagnosis of Alzheimer's Disease
  • Screening of Other Health Conditions of People Suffering from Alzheimer's Disease
  • Importance of Comprehensive Clinical Evaluation in the Case of Alzheimer's Disease Patients
  • Education Sector
  • Sports
  • Other Applications
  • Cognitive Impairment in People Suffering from Parkinson's Disease
  • Treatment of Parkinson's Disease Dementia
  • Cognitive Decline in Patients Suffering from Parkinson's Disease Causing Further Complexities

Chapter 6 Global Cognition and Memory-enhancing Drugs Market Breakdown by Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia
  • ROW
  • Brazil
  • Turkey
  • South Africa

Chapter 7 Patent Review

  • Patent Analysis
  • Patents Filed in Asia-Pacific
  • Patents Filed in North America

Chapter 8 Analysis of Market Opportunities

  • Product Approval
  • Business Collaboration

Chapter 9 Company Profiles

  • ACCELERATED INTELLIGENCE INC.
  • Overview
  • Products
  • ALLERGAN PLC
  • Overview
  • Products
  • ALTERNASCRIPT LLC
  • Overview
  • Products
  • CAMBRIDGE COGNITION
  • Overview
  • Products
  • CERETROPIC
  • Overview
  • Products
  • COGNITION THERAPEUTICS INC.
  • Overview
  • Products
  • COGSTATE LTD.
  • Overview
  • Products
  • HVMN
  • Overview
  • Products
  • NOOTRIMENT
  • Overview
  • Products
  • NOVARTIS AG
  • Overview
  • ONNIT LABS LLC
  • Overview
  • Products
  • PEAK NOOTROPICS
  • Overview
  • Products
  • PFIZER INC.
  • Overview
  • Products
  • PURELIFE BIOSCIENCE CO., LTD.
  • Overview
  • Products
  • SHIRE
  • Overview
  • Products
  • SUPNOOTROPIC BIO CO., LTD.
  • Overview
  • Products
  • TEVA PHARMACEUTICALS INDUSTRIES LTD. (BARR PHARMACEUTICALS)
  • Overview
  • Products

Chapter 10 Appendix: Patents, Drugs and Cognitive Enhancers

  • List of Patents North America
  • List of Patents Applied Globally
  • List of Drugs and Cognitive Enhancers
  • 1,3-Dimethylamylamine
  • 5-HTP
  • Acetyl L-Carnitine
  • Adrafinil
  • Agmatine
  • Alpha-GPC
  • Alpha-Lipoic Acid
  • Aniracetam
  • Bacopa Monnieri
  • Blueberry
  • Boswellia Serrata
  • Caffeine
  • CDP-Choline
  • Celastrus Paniculatus
  • Clitoria Ternatea (Shanka Pushpi)
  • Cocoa Flavanols
  • Coluracetam
  • Convolvulus Pluricaulis (Shankhapushpi)
  • Creatine
  • D-Serine
  • Dehydroepiandrosterone
  • Dimocarpus Longan
  • Emblica Officinalis (Amla)
  • Fish Oil (DHA, EPA, Omega-3)
  • GABA
  • Ginkgo biloba
  • Glycine
  • Gotu Kola (Centella Asiatica)
  • Grape Seed Extract
  • Green Tea Catechins
  • Hordenine
  • Huperzine-A
  • Idebenone
  • Kava
  • Krill Oil
  • L-DOPA
  • L-Tyrosine
  • Magnolia Officinalis
  • Melissa Officinalis (Lemon Balm)
  • Modafinil
  • Morus Alba
  • Mucuna Pruriens
  • Muira Puama
  • Nardostachys Jatamansi
  • Nefiracetam
  • Nicotine
  • Nigella Sativa
  • Noopept
  • Oxiracetam
  • Panax Ginseng
  • Phenylethylamine
  • Phenylpiracetam
  • Phosphatidylserine
  • Piracetam
  • Polygala Tenuifolia
  • Pramiracetam
  • PRL-8-53
  • Pueraria Lobata
  • Pycnogenol
  • Pyritinol
  • Resveratrol
  • Rhodiola Rosea
  • S-Adenosyl Methionine
  • Sarcosine
  • Scutellaria baicalensis
  • Sulbutiamine
  • Sunifiram
  • Theanine
  • Uridine
  • Vinpocetine
  • Vitamin B12
  • Yamabushitake
  • Yerba Mate
  • Zinc

List of Tables
Summary Table: Global Market for Cognition and Memory-enhancing Drugs, by Region, Through 2022
Table 1: Key Trends in Global Cognition Drugs and Memory Enhancers
Table 2: Drugs Used to Enhance Cognitive Function
Table 3: Global Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 4: Global Market for Aricept, by Region, Through 2022
Table 5: Global Market for Exelon, by Region, Through 2022
Table 6: Administration of Exelon
Table 7: Global Market for Reminyl, by Region, Through 2022
Table 8: Companies Manufacturing Reminyl
Table 9: Global Market for Namenda, by Region, Through 2022
Table 10: Global Market for Adderall, by Region, Through 2022
Table 11: Global Market for Ritalin, by Region, Through 2022
Table 12: Global Market for Dexedrin, by Region, Through 2022
Table 13: Global Market for Other Cognition and Memory-enhancing Drugs, by Region, Through 2022
Table 14: Causes of Dementia and Associated Characteristics
Table 15: Global Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 16: Global Cognition and Memory-enhancing Drugs Market for Alzheimer’s Disease, by Region, Through 2022
Table 17: Causes of Dementia and Associated Characteristics
Table 18: Global Cognition and Memory-enhancing Drugs Market in the Education Sector, by Region, Through 2022
Table 19: Global Cognition and Memory-enhancing Drugs Market in Sports, by Region, Through 2022
Table 20: Global Cognition and Memory-enhancing Drugs Market in Other Applications, by Region, Through 2022
Table 21: Global Market for Cognition and Memory-enhancing Drugs, by Region, Through 2022
Table 22: North American Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 23: North American Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 24: North American Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 25: European Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 26: European Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 27: European Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 28: Asia-Pacific Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 29: Asia-Pacific Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 30: Asia-Pacific Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 31: Rest of the World Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 32: Rest of the World Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 33: Rest of the World Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 34: Patent Review of Cognition Drugs Market, 2013-2016
Table 35: Patent Review of Cognition Drugs Market, by Region, 2013-2016
Table 36: Allergan’s Financials, 2014-2016
Table 37: Allergan’s Developments, 2014-2017
Table 38: Cognition Therapeutics' Developments, 2014-2017
Table 39: Novartis’ Financials, 2014-2016
Table 40: Novartis’ Developments, 2014-2017
Table 41: Pfizer’s Financials, 2014-2016
Table 42: Pfizer’s Developments, 2014-2017
Table 43: Shire’s Financials, 2014-2016
Table 44: Teva’s Financials, 2014-2016
Table 45: Teva’s Developments, 2014-2017
Table 46: List of Patents, North America
Table 47: List of Patents Applied Globally

List of Figures
Summary Figure: Global Market for Cognition and Memory-enhancing Drugs, by Region, 2016-2022
Figure 1: Medication Overdose: Cognitive Impairment
Figure 2: Acetylcholinesterase Inhibitor Used in the Alzheimer’s Disease Management
Figure 3: Role of Modafinil in the Management of Alzheimer’s Disease
Figure 4: Off-license use of Pharmacological Cognitive-Enhancing Drugs
Figure 5: Risk Associated with the Excessive Use of Cannabis
Figure 6: Role of Adolescence in the Cognition Process
Figure 7: Statistical Analysis of Aging Population in the U.S.
Figure 8: Global Market Segmentation for Cognition and Memory-enhancing Drugs, by Type
Figure 9: Global Market for Cognition and Memory-enhancing Drugs, by Application
Figure 10: The Stages of Alzheimer’s Disease
Figure 11: The Stages of Parkinson’s Disease
Figure 12: U.S. Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 13: Canadian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 14: Mexican Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 15: U.K. Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 16: German Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 17: French Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 18: Rest of Europe Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 19: Chinese Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 20: Japanese Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 21: Australian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 22: Indian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 23: Rest of Asia-Pacific Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 24: Brazilian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 25: Turkey’s Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 26: South African Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 27: Strategies for Global Cognition and Memory-enhancing Drugs Market, 2014-2017
Figure 28: Market Players Adopting Several Strategies for Global Cognition and Memory-enhancing Drugs Market, 2014-2017

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Accelerated Intelligence Inc.
  • Allergan Plc
  • Alternascript Llc
  • Cambridge Cognition
  • Ceretropic
  • Cognition Therapeutics Inc.
  • Cogstate Ltd.
  • HVMN
  • Nootriment
  • Novartis Ag
  • Onnit Labs Llc
  • Peak Nootropics
  • Pfizer Inc.
  • Purelife Bioscience Co., Ltd.
  • Shire
  • Supnootropic Bio Co., Ltd.
  • Teva Pharmaceuticals Industries Ltd. (Barr Pharmaceuticals)
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll